Brighter continues to grow in the United Arab Emirates – recruits Medical Supervisor.
Brighter recruits Irene Kidhall Bragd as Medical Supervisor in the United Arab Emirates. Irene is a Senior Consultant and specialist in internal medicine, with deep knowledge in treatment of chronic conditions, and has worked in Danderyd Hospital in Stockholm for almost 25 years.
"Irene, with her extensive experience in healthcare, provides vital knowledge and security that will be of great value when healthcare professionals and users for the first time in a real-life situation come into contact with Actiste. We are very pleased to have her with us," says Truls Sjöstedt, Brighter's CEO and founder.
As Medical Supervisor at Brighter, Irene will strengthen the company's collaboration with hospitals and health clinics in the United Arab Emirates, where Brighter recently established a subsidiary together with AFAQ Group. Irene will also oversee the education of healthcare staff and future Actiste users in the region, as well as supervise treatments and clinical trials.
“Brighter has created a very intriguing solution that benefits both the patient and the healthcare staff. Healthcare providers has always been struggling with adherence in treatments and uncertainty about how the patient is managing their health in between their care visits. This is a game-changer," says Irene Kidhall Bragd, Medical Supervisor, Brighter.
Irene will assume the role effective immediately and will be based in Dubai.
For further information, please contact:
Truls Sjöstedt, CEO
Phone: +46 709 73 46 00
Email: truls.sjostedt@brighter.se
Henrik Norström, COO
Phone: +46 733 40 30 45
Email: henrik.norstrom@brighter.se
About Actiste
Brighter's solution Actiste® handles most of the self-monitoring and treatment of insulin-treated diabetes in a single easy-to-use device. Measurement of glucose levels, insulin injections, automatic logging, and timing of all activities are performed from a single unit. Actiste is connected via an autonomous and secure mobile connection, and information can be automatically shared with selected recipients through The Benefit Loop®, Brighter's open cloud-based service where data is collected, processed and analyzed with patient consent.
Validated user-generated data, such as glucose levels or insulin doses, can be automatically transferred electronically to many different constituents. The patient selects when and how data is shared and who will have access to it. Through The Benefit Loop, different services can motivate patients with chronic illnesses to change their behavior, which can save lives, reduce relatives' concerns, and release enormous healthcare resources. www.actiste.com
About Brighter
Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of healthcare’s biggest challenges: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing, and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop® - is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and their close associates, healthcare providers, research institutes, the pharmaceutical industry, and society as a whole. www.brighter.se
The Company's shares are listed on NASDAQOMX First North/BRIG. Brighter’s Certified Adviser on Nasdaq OMX First North is Eminova Fondkommission AB, +46 (0)8 – 684 211 00, info@eminova.se, www.eminova.se.